Age‑Dependent Shift in ERK1/2 Nucleocytoplasmic Shuttling Drives Senescence via Cytoplasmic ROS Signaling

Hypothesis

In naturally aged, non‑senescent cells, altered expression and activity of the import machinery (importin7) and export regulator (PEA‑15) slow ERK1/2 nuclear import while accelerating its export, trapping active ERK in the cytoplasm. This mislocalization sustains cytoplasmic ERK‑dependent ROS production and mitochondrial MAPK signaling, which triggers senescence‑associated phenotypes independent of nuclear ERK functions. Restoring youthful importin7 levels or inhibiting PEA‑15 re‑establishes rapid nucleocytoplasmic cycling, reduces cytoplasmic ROS, and delays senescence onset without global MEK/ERK inhibition.

Mechanistic Basis

Aging is associated with oxidative modification of importin7’s Ran‑binding domain, diminishing its affinity for phosphorylated ERK and decreasing nuclear import rates【4】(https://pmc.ncbi.nlm.nih.gov/articles/PMC6323238/). Concurrently, chronic low‑grade NF‑κB activation from the senescence‑associated secretory phenotype upregulates PEA‑15 transcription, enhancing ERK nuclear export and cytoplasmic sequestration【5】(https://doi.org/10.1038/cddis.2013.445). The resulting kinetic bias yields a higher cytoplasmic:nuclear pERK ratio. Cytoplasmic ERK phosphorylates substrates such as BAD and mitochondrial complexes, elevating ROS production【1】(https://pmc.ncbi.nlm.nih.gov/articles/PMC3650227/). Increased ROS feeds back to activate p16^INK4a^ and p21^CIP1^, enforcing cell‑cycle arrest. Importantly, nuclear ERK‑driven transcriptional programs that promote proliferation remain under‑represented because the brief nuclear visits fail to sustain sufficient phosphorylation of transcription factors like ELK1.

Testable Predictions

1. Shuttling kinetics – Live‑cell FRAP or FLIP of ERK2‑GFP will show a significant increase in nuclear import half‑time and a decrease in export half‑time in fibroblasts from donors >65 y compared with <30 y, correlating with elevated cytoplasmic pERK measured by subcellular fractionation.
2. Importin7/PEA‑15 manipulation – siRNA‑mediated knockdown of importin7 in young cells will phenocopy the aged shuttling pattern and raise senescence markers (SA‑β‑gal, p16). Overexpression of importin7 or CRISPR‑mediated PEA‑15 knockout in aged cells will restore rapid shuttling, lower cytoplasmic ROS, and reduce senescence markers without affecting total ERK activity.
3. ROS causality – Targeted expression of a mitochondria‑localized ERK‑phosphorylating construct (mito‑ERK2) in aged cells will rescue the senescence phenotype even when importin7 remains low, indicating that cytoplasmic ERK‑ROS signaling is sufficient to drive arrest.
4. Pharmacological rescue – Small‑molecule stabilizers of importin7‑Ran interaction (e.g., analogues of ivermectin that enhance importin affinity) will decrease senescence incidence in aged human keratinocyte cultures, whereas PEA‑15 stabilizing peptides will exacerbate it.

Potential Challenges and Alternatives

If importin7 or PEA‑15 manipulations fail to alter senescence despite correcting shuttling, the hypothesis would be falsified, suggesting that other age‑altered scaffolds (e.g., KSR1, MP1) or DUSP compartmentalization dominate ERK signaling outcomes. Conversely, observing that global ERK activity must be suppressed to affect senescence would indicate that localization changes are epiphenomenal rather than causal.

This framework moves beyond activity‑centric models by proposing that the timing of ERK’s nuclear presence, governed by age‑sensitive transport proteins, determines whether ERK signaling fuels proliferation or initiates a cytoplasmic ROS‑driven senescence program.